相关实验视频

Updated: Jan 18, 2026

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

新兴的HER2向免疫疗法用于胆管癌

Prin Sungwan¹, Jutatip Panaampon^1,2, Ratchaneewan Sumankan^1,3

¹Division of Hematopoiesis, Joint Research Center for Human Retrovirus Infection & Graduate School of Medical Sciences, Kumamoto University 2-2-1 Honjo, Chuo-ku, Kumamoto, 860-0811, Japan.

Oncology research

|September 8, 2025

概括

向人类表皮生长因子受体2 (HER2) 显示出对胆管癌 (CCA) 免疫疗法的希望. HER2 变化与更差的预后有关,这表明针对 HER2 的策略可能有利于特定的 CCA 患者群体.

科学领域:

在瘤学瘤学.
免疫治疗是一种免疫疗法.
分子生物学分子生物学

背景情况:

胆管癌 (CCA) 是一种致命的胆管癌,对化疗反应不佳.
人类表皮生长因子受体2 (HER2) 与癌症进展有关.
在乳腺癌和胃癌中,HER2是已验证的标,但在CCA方面尚未确定.

研究的目的:

探索在胆管癌 (CCA) 免疫治疗中向HER2的潜力.
审查针对CCA的HER2向疗法的进展.
评估支持HER2作为CCA治疗点的证据.

主要方法:

在CCA中HER2变化的文献综述.
评估目前针对HER2的治疗方法.
评估动物模型在CCA疗法开发中的作用.

主要成果:

HER2 变化与肝炎相关的 CCA 的预后较差有关.
最近的进展表明,在CCA中,针对HER2的向疗法具有潜力.
HER2正在成为CCA免疫治疗的有希望的目标.

结论:

针对HER2为特定的胆管癌 (CCA) 患者群体提供了潜在的新策略.
针对CCA,需要对HER2向疗法的进一步研究和开发.
专注于HER2表达可能会改善CCA的治疗结果.

关键词:

胆性瘤是一种胆性瘤.癌症研究的动物模型.人类表皮生长因子受体2 (HER2)免疫疗法免疫疗法

更多相关视频

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...